Pfizer’s experimental influenza vaccine will not receive approval absent new data proving it protects seniors against the flu, the commissioner of the Food and Drug Administration suggested in a new interview.
The messenger ribonucleic acid (mRNA) shot “failed in seniors,” Dr. Marty Makary, the FDA commissioner, said during an appearance on Nov. 29 on Fox News. “The trial showed zero benefit.”
He added: “We’re not just going to rubber stamp new products that don’t work, that fail in a clinical trial. It makes a mockery of science if we’re just going to rubber stamp things with no data.”…